Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European Stocks Seen Higher Amid Fresh Vaccine Hopes

Published 09/14/2020, 02:04 AM
Updated 09/14/2020, 02:05 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are seen opening higher Monday, boosted by renewed hopes of prompt delivery of a coronavirus vaccine. However, caution ahead of upcoming central bank meetings may limit the gains.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 1% higher, CAC 40 futures in France climbed 0.5%, while the FTSE 100 futures contract in the U.K. rose 0.4%.

AstraZeneca (NYSE:AZN) announced Saturday that it had resumed phase 3 trials of its Covid-19 vaccine candidate, which it is developing with the University of Oxford, after the relevant U.K. authorities gave their approval.

The trials had been halted last week after a patient came down with an unspecified illness, casting doubt on the timing of the rollout of the vaccine, one of the most advanced in development.

Additionally, a day later, Pfizer (NYSE:PFE) CEO Albert Bourla said the company’s own candidate, co-developed with German drug maker BioNTech, has a “good chance” of submitting key data from late-stage trials by the end of October, and once approved, could be rolled out to Americans by the end of the year. 

Investors have long been looking for a vaccine to allow people across the world to return to the work and consumption habits they had before the pandemic and its lockdowns.

However, there is also likely to be a degree of caution shown ahead of a number of important central bank meetings later this week. 

The U.S. Federal Reserve concludes its two-day policy meeting on Wednesday. It’s expected to update its projections for the economic and interest rate outlook, which will include forecasts for 2023 for the first time. 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Bank of Japan and the Bank of England will also announce their respective policy decisions on Thursday.

In corporate news, Euronext (PA:ENX) will be in focus after saying Monday that it has submitted a non-binding offer to acquire Borsa Italiana from London Stock Exchange Group (LON:LSE).

This is set to spark a takeover battle for the Italian exchange as Deutsche Boerse (DE:DB1Gn) submitted an offer on Friday.

Oil prices strengthened Monday as another fierce storm in the Gulf of Mexico caused rigs to shut down production.

Tropical Storm Sally is gaining strength in the Gulf of Mexico and is forecast to be a category 2 hurricane. This is the second weather disruption to oil production in less than a month, with Hurricane Laura forcing shutdowns less than three weeks earlier. Sally is expected to make landfall near New Orleans on Tuesday.

U.S. crude futures traded 0.5% higher at $37.53 a barrel, while the international benchmark Brent contract rose 0.3% to $39.93. 

Elsewhere, gold futures rose 0.5% to $1,957.20/oz, while EUR/USD traded 0.1% higher at 1.1851.

Latest comments

Vaccine Fake Running This Market From March...
Both of you are 100% correct. Even if there is a vaccine what about the 2 year test period and side effects that no one knows what it could be
lost track of how many times vaccine has been used as an excuse by day-traders to generate movements in markets. inconvenient truth is: no one knows how effective the vaccines in development are, because they are rushed to markets.  China already has a vaccine (tested and used by its defense forces), and if it's any good, why not just take it? Russia has a vaccine too, so what?
You won't stop with "vaccine" even though you know it's nothing more than retail hype news with no substance, correct?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.